器官短缺时代用于器官分配的不可接受人类白细胞抗原对肾移植等待时间的影响
该研究评估了德国六个移植中心3264例等待名单患者至少2年的肾移植情况,计算因不可接受抗原(UAGs)排除供肾的比例(虚拟群体反应性抗体,vPRA)。在Eurotransplant肾脏分配方案中,vPRA每增加1%相当于额外等待2.5周;在Eurotransplant老年项目中,vPRA>50%的患者移植概率显著降低,vPRA每增加1%相当于额外等待5周。研究认为UAGs因补偿机制不足而降低移植概率。
要点
- 在Eurotransplant肾脏分配方案中,vPRA每增加1%相当于额外等待2.5周。
- 标准风险患者中,vPRA每增加1%仅需额外等待1.3周。
- 在Eurotransplant老年项目中,vPRA>50%的患者移植概率显著降低。
核心结论
- 本研究表明,由于补偿机制不足,分配UAGs在两个主要Eurotransplant分配方案中均降低了移植概率。
- 目前对于免疫致敏患者,需将延长等待时间与未分配为UAGs的供者特异性抗体带来的免疫风险增加进行权衡。
研究设计与样本
- 研究评估了德国六个移植中心等待名单上3264例患者的肾移植情况,观察期至少2年。
- 通过计算虚拟群体反应性抗体(vPRA)来评估因UAGs排除供肾的比例。
- 使用来自七个中心1521例患者的外部验证队列对模型进行验证。
主要发现
- 在Eurotransplant肾脏分配方案中,探索性单变量分析显示移植概率不受vPRA影响。
- 在多变量模型中,vPRA值每增加1%相当于额外等待2.5周。
- 若仅考虑标准风险患者(例如无其他器官同时移植),仅需额外等待1.3周。
- 在Eurotransplant老年项目中,未调整分析显示vPRA值>50%的患者移植概率显著降低。
- 在Eurotransplant老年项目的多变量模型中,vPRA值每增加1%相当于额外等待5周。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The assignment of human leucocyte antigens (HLAs) against which antibodies are detected as unacceptable antigens (UAGs) avoids allocation of HLA- incompatible allografts. There is uncertainty as to what extent UAGs decrease the probability of receiving a kidney offer. METHODS: Kidney transplantations in 3264 patients on the waiting lists of six German transplant centres were evaluated for a period of at least 2 years. The proportion of excluded offers due to UAGs was calculated as virtual panel-reactive antibodies (vPRAs). RESULTS: In the common Eurotransplant Kidney Allocation Scheme, the transplant probability was unaffected by vPRAs in exploratory univariate analyses. In the multivariable model, a 1% increase in vPRA values was outweighed by an additional waiting time of 2.5 weeks. The model was confirmed using an external validation cohort of 1521 patients from seven centres. If only patients with standard risk were considered (e.g. no simultaneous transplantation of other organs), only 1.3 weeks additional waiting time was needed. In the Eurotransplant Senior Program, patients with vPRA values >50% had a strongly reduced transplant probability in the unadjusted analyses. In the multivariable model, a 1% increase in vPRA values was outweighed by an additional waiting time of 5 weeks. CONCLUSIONS: This study demonstrates that the assignment of UAGs decreases the transplant probability in both main Eurotransplant allocation programs because of insufficient compensatory mechanisms. At present, for immunized patients, a prolonged waiting time has to be weighed against the increased immunologic risk due to donor-specific antibodies not assigned as UAGs.
引用
- Ziemann M, Heßler N, König IR, et al. Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation. Nephrol Dial Transplant. 2017. PMID: 28340245. doi:10.1093/ndt/gfw462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。